PRPO – Precipio Inc
PRPO
$18.75Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $30,359,104.00
EPSttm : -1.19
Precipio, Inc.
$18.75
Float Short %
0.1
Margin Of Safety %
-31
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
18.85
Target Price
19
Analyst Recom
1
Performance Q
18.49
Relative Volume
0.4
Beta
1.13
Ticker: PRPO
22 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-09-08 | PRPO | 21.43 | N/A | N/A | 0 |
2025-09-09 | PRPO | 21.2 | N/A | N/A | 0 |
2025-09-10 | PRPO | 20.98 | N/A | N/A | 0 |
2025-09-11 | PRPO | 20.2303 | N/A | N/A | 0 |
2025-09-12 | PRPO | 19.51 | N/A | N/A | 0 |
2025-09-15 | PRPO | 18.78 | N/A | N/A | 0 |
2025-09-16 | PRPO | 18.4 | N/A | N/A | 0 |
2025-09-17 | PRPO | 17.55 | N/A | N/A | N/A |
2025-09-18 | PRPO | 17.57 | N/A | N/A | 0 |
2025-09-19 | PRPO | 16.44 | N/A | N/A | 0 |
2025-09-22 | PRPO | 17.25 | N/A | N/A | 0 |
2025-09-23 | PRPO | 17.74 | N/A | N/A | 0 |
2025-09-24 | PRPO | 17.28 | N/A | N/A | 0 |
2025-09-25 | PRPO | 18.1 | N/A | N/A | 0 |
2025-09-26 | PRPO | 17.19 | N/A | N/A | 0 |
2025-09-29 | PRPO | 18.58 | N/A | N/A | 0 |
2025-09-30 | PRPO | 17.79 | N/A | N/A | 0 |
2025-10-01 | PRPO | 20.6 | N/A | N/A | 0 |
2025-10-02 | PRPO | 20.19 | N/A | N/A | 0 |
2025-10-03 | PRPO | 21 | N/A | N/A | 0 |
2025-10-06 | PRPO | 20.17 | N/A | N/A | 0 |
2025-10-07 | PRPO | 18.92 | N/A | N/A | 0 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-09-08 | PRPO | 20.99 | - | - | - |
2025-09-09 | PRPO | 21.25 | - | - | - |
2025-09-10 | PRPO | 21.17 | - | - | - |
2025-09-11 | PRPO | 20.23 | - | - | - |
2025-09-12 | PRPO | 19.51 | - | - | - |
2025-09-15 | PRPO | 18.72 | - | - | - |
2025-09-16 | PRPO | 18.41 | - | - | - |
2025-09-17 | PRPO | 17.93 | - | - | - |
2025-09-18 | PRPO | 17.57 | - | - | - |
2025-09-19 | PRPO | 16.00 | - | - | - |
2025-09-22 | PRPO | 17.25 | - | - | - |
2025-09-23 | PRPO | 17.98 | - | - | - |
2025-09-24 | PRPO | 17.39 | - | - | - |
2025-09-25 | PRPO | 17.87 | - | - | - |
2025-09-26 | PRPO | 17.42 | - | - | - |
2025-09-29 | PRPO | 18.24 | - | - | - |
2025-09-30 | PRPO | 18.49 | - | - | - |
2025-10-01 | PRPO | 20.40 | - | - | - |
2025-10-02 | PRPO | 20.46 | - | - | - |
2025-10-03 | PRPO | 20.91 | - | - | - |
2025-10-06 | PRPO | 20.13 | - | - | - |
2025-10-07 | PRPO | 18.85 | - | - | - |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-09-08 | PRPO | 6.40 | -18.84 | 0.53 |
2025-09-09 | PRPO | 6.40 | -18.84 | 0.53 |
2025-09-10 | PRPO | 3.69 | -18.84 | 0.53 |
2025-09-11 | PRPO | 3.69 | -18.84 | 0.10 |
2025-09-12 | PRPO | 3.69 | -18.84 | 0.10 |
2025-09-15 | PRPO | 3.69 | -18.93 | 0.10 |
2025-09-16 | PRPO | 3.80 | -18.93 | 0.10 |
2025-09-17 | PRPO | 3.80 | -18.93 | 0.10 |
2025-09-18 | PRPO | 3.80 | -18.93 | 0.10 |
2025-09-19 | PRPO | 3.80 | -18.93 | 0.10 |
2025-09-22 | PRPO | 3.80 | -18.80 | 0.10 |
2025-09-23 | PRPO | 3.80 | -18.80 | 0.10 |
2025-09-24 | PRPO | 3.80 | -18.80 | 0.10 |
2025-09-25 | PRPO | 3.80 | -18.80 | 0.10 |
2025-09-26 | PRPO | 3.80 | -18.80 | 0.10 |
2025-09-29 | PRPO | 3.80 | 0.09 | 0.10 |
2025-09-30 | PRPO | 3.80 | 0.09 | 0.10 |
2025-10-01 | PRPO | 3.80 | 0.09 | 0.10 |
2025-10-02 | PRPO | 3.80 | 0.09 | 0.10 |
2025-10-03 | PRPO | 3.80 | 0.09 | 0.10 |
2025-10-06 | PRPO | 3.76 | -2.38 | 0.10 |
2025-10-07 | PRPO | 3.76 | -2.38 | 0.10 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
3.76
Institutional Transactions
-2.38
Beta
1.13
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
13.08
Quality Score
44
Growth Score
55
Sentiment Score
99
Actual DrawDown %
89.7
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.43
P/B
2.31
P/Free Cash Flow
54.21
EPS
-1.21
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8.48
Relative Volume
0.4
Return on Equity vs Sector %
-39.8
Return on Equity vs Industry %
-25.5
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading